NEW YORK – Researchers from the Broad Institute, Massachusetts General Hospital, Color, and elsewhere have found that polygenic background can modify the penetrance of disease risk variants in tier 1 genomic conditions such as familial hypercholesterolemia, hereditary breast and ovarian cancer, and Lynch syndrome.